Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design.

Muideen T Olaiya,Nadine E Andrew,Lachlan L Dalli,David Ung,Joosup Kim,Dominique A Cadilhac, Peter Wood, Janet May,Ben Clissold,Monique F Kilkenny

Neuroepidemiology（2022）

引用 0|浏览7

暂无评分

摘要

The real-world effectiveness of treatment with lipid-lowering medications after stroke is attenuated when evaluated based on prevalent-user rather than new-user design. These findings may have implications for designing studies on the real-world effectiveness of secondary prevention medications.

查看译文

关键词

Adherence,Bias,Mortality,Outcomes,Secondary prevention,Stroke

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要